BioStem Technologyes, Inc. (BSEM) sees shares rise from $1 to over $9 and there may be no end in sight....Catalysts are piling up for this fast-growing biotech company which may be one of the biggest biotech darlings in the making. As regenerative medicine continues to find its way into the mainstream, emerging biotech company BioStem Technologies, Inc. (OTC: BSEM) is making waves for its focus on harnessing elements of perinatal tissue derived from the human placenta for manufacturing structural tissue allografts to heal wounds. This includes a curated suite of versatile products called Vendaje. The company has been capturing Wall Street's attention as its share price has risen from around $1 in July of 2023 to as high as $7.00 by year-end. This year share prices have exceeded $9! One of the most exciting catalysts for potential growth comes from a recent price target increase from notable research firm Zack's Small Cap Research. It comes shortly after the company released preliminary and unaudited numbers that showed net revenue for 4Q2023 of $11.5 million, a more than 1300% increase from the year ago period! This message is a PAID ADVERTISEMENT for BioStem Technologies Inc. (OTC: BSEM) from Sideways Frequency. StockEarnings, Inc receives a fixed fee for each subscriber that clicks on a link in this email, totaling up to $2,000. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either BioStem Technologies Inc. (OTC: BSEM) or Sideways Frequency. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding BioStem Technologies Inc. (OTC: BSEM) on Huge Alerts website for additional information about the relationship between Sideways Frequency and BioStem Technologies Inc. (OTC: BSEM). Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click Unsubscribe. StockEarnings, Inc |
Today's Bonus Content: Jeff Bezos backs tiny biotech with $130 mil investment
No comments:
Post a Comment